Načítá se...
Checkpoint Inhibitors in Breast Cancer - Current Status and Future Directions
Antineoplastic agents directly targeting tumor cells have represented the major strategy of systemic anticancer therapy for many years. Nevertheless, overcoming resistance mechanisms remains a great challenge because treatment options are limited in many cases. From this point of view, immunotherape...
Uloženo v:
| Vydáno v: | Breast Care (Basel) |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
S. Karger GmbH
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6016055/ https://ncbi.nlm.nih.gov/pubmed/29950964 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000486706 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|